Home
Torrent Pharmaceuticals Ltd PE Ratio

Torrent Pharmaceuticals Ltd
NSE: TORNTPHARM
PE
Key Highlights
- The P/E Ratio of Torrent Pharmaceuticals Ltd is 55.4 as of 19 Feb 14:46 PM .
- The P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 53.2 on March 2024 . This represents a CAGR of 10.29% over 5 years.
- The Latest Trading Price of Torrent Pharmaceuticals Ltd is ₹ 3108 as of 19 Feb 14:36 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Torrent Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Torrent Pharmaceuticals Ltd
Company Fundamentals for Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd
NSE: TORNTPHARM
Share Price
Market Price of Torrent Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
18 Feb 2025 | 3046.3 |
17 Feb 2025 | 3077.05 |
14 Feb 2025 | 3011.5 |
13 Feb 2025 | 3074.75 |
12 Feb 2025 | 3063.05 |
11 Feb 2025 | 3104.95 |
10 Feb 2025 | 3190.6 |
07 Feb 2025 | 3259.4 |
06 Feb 2025 | 3161.35 |
05 Feb 2025 | 3115.7 |
SWOT Analysis Of Torrent Pharmaceuticals Ltd
BlinkX Score for Torrent Pharmaceuticals Ltd
Asset Value vs Market Value of Torrent Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Torrent Pharmaceuticals Ltd | 103096 | 55.37 |
Sun Pharmaceuticals Industries Ltd | 408259 | 34.6 |
Divis Laboratories Ltd | 154917 | 74.9 |
Cipla Ltd | 119705 | 24.0 |
Dr Reddys Laboratories Ltd | 99951 | 18.6 |
Mankind Pharma Ltd | 98468 | 48.2 |
Company | |
---|---|
Torrent Pharmaceuticals Ltd | 103096 |
Sun Pharmaceuticals Industries Ltd | 408259 |
Divis Laboratories Ltd | 154917 |
Cipla Ltd | 119705 |
Dr Reddys Laboratories Ltd | 99951 |
Mankind Pharma Ltd | 98468 |
PE Ratio of Torrent Pharmaceuticals Ltd Explained
₹103096
Market cap
₹1862
Earnings
55.4X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Torrent Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Torrent Pharmaceuticals Ltd
Historical Revenue, EBITDA and Net Profit of Torrent Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Torrent Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Torrent Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Torrent Pharmaceuticals Ltd
About Torrent Pharmaceuticals Ltd
- Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets.
- The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
- It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.
- Apart from this, it has a modern and well-equipped state-of-the-art R&D Centre at Bhat near Ahmedabad, built with an investment of US $ 40 million.
Torrent Pharmaceuticals Ltd News Hub
Torrent Pharmaceuticals announces change in senior management
Torrent Pharmaceuticals announced that Pranav Mehta has been elevated as Executive Director from Vic
Read more
13 Aug 24
Torrent Pharma hits life as Gujarat unit gets EIR from USFDA
Earlier on 12 June 2024, the pharmaceutical company informed that the US FDA had conducted a pre-app
Read more
30 Aug 24
Torrent Pharma's Madhya Pradesh facility concludes GMP inspection with 1 observation
The GMP inspection was conducted from 16 September to 20 September 2024. At the conclusion of the in
Read more
20 Sept 24
Torrent Pharmaceuticals announces board meeting date
Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 October 2
Read more
10 Oct 24